This article presents the results of a survey conducted to gain insight on the impact of the COVID-19 pandemic on biomanufacturing operations.
Jacqueline Wolfrum
Advertisement
Jacqueline Wolfrum, jwolfrum@mit.edu, is co-director, Biomanufacturing Program, and director, BioMAN, MIT Center for Biomedical Innovation.
Articles by Jacqueline Wolfrum
Advertisement
Latest Updated Articles
The Impact of SARS-CoV-2 on Biomanufacturing OperationsPublished: August 2nd 2020 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
